A paradigm shift in recreational drug use: The challenge of legal highs in New Zealand

New Zealand Medical Journal

Volumn 124, Issue 1339, 2011, Pages 99-101

  Wilkins, Chris ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 4 METHYL 2 HEXYLAMINE; BENZYLPIPERAZINE; CANNABIS DERIVATIVE; CP 47 497; ILLICIT DRUG; JWH 073; PIPERAZINE DERIVATIVE; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

DRUG ABUSE; DRUG CONTROL; HUMAN; LETTER; MARKETING; NEW ZEALAND;

HUMANS; NEW ZEALAND; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 79961077372     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Expert Advisory Committee on Drugs. Synthetic Cannabinomimetic Substances: JWH-018 and JWD-073. Wellington: EACD, 2010, 11 November. Agenda Item 4.
2. United Nations Office on Drugs and Crime. Synthetic cannabinoids in herbal products: UNODC, 2011.
3. Griffiths P, Sedefov R, Gallegos A, Lopez D. How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' case study. Addiction 2010;105:951-3.
4. Wilkins C, Sweetsur P. Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: A case of effective industry self regulation? International Journal of Drug Policy 2010;21:86-90.
5. Dudding A. 'Someone will make money...it might as well be me'. Sunday Star Times, 26 June; 2011 [cited 14 July 2011]; Available from: http://www.stuff.co.nz/sunday-startimes/features/5191660/Someone-will-make-money-it-might-as-well-be-me
6. United Nations Office on Drugs and Crime (UNODC). Overview of global and regional drug trends and patterns. World Drug Report. Vienna: UNODC; 2011.
7. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2009: The State of the Drugs Problem in Europe. Lisbon, Portugal: EMCDDA, 2009.
8. European Monitoring Centre for Drugs and Drug Addiction. First international multidisciplinary forum on new drugs, 11-12 May 2011, Lisbon: Concluding remarks. EMCDDA; 2011 [cited 14 July, 2011]; Available from: http://www.emcdda.europa.eu/news/2011/new-drugs-forum-conclusion
9. New Zealand Law Commission. Controlling and Regulating Drugs - A Review of the Misuse of Drugs Act 1975. Wellington, 2011, 3 May
10. Expert Advisory Committee on Drugs. Advice from the Expert Advisory Committee on Drugs on 1,3 dimethylamylamine (DMAA), [letter to Peter Dunne, Associate Minister of Health]. Wellington: EACD, 2009. 21 September.
11. Expert Advisory Committee on Drugs. Advice from the Expert Advisory Committee on Drugs on salvia [letter to Jim Anderton, Associate Minister of Health]. Wellington: EACD, 2007, 17 December.
12. Wilkins C, Sweetsur P, Huckle T, et al. The impact of the prohibition of BZP on the use and harm of BZP in New Zealand. Auckland: Centre for Social and Health Outcomes Research and Evaluation, Massey University, 2009.